期刊文献+

妊娠高血压疾病患者治疗前后血清白介素-6、8、10水平的变化 被引量:3

Changes of serum interleukin-6, 8, and 10 of hypertensive disorder complicating pregnancy(HDCP) patients before and after medical treatment
下载PDF
导出
摘要 目的观察妊娠高血压疾病(HDCP)患者治疗前后血清白介素(IL)-6、8、10水平变化。方法 50例HDCP患者(观察组)予以解痉、镇静、控制血压和利尿等对症治疗1周。观察治疗前后血清IL-6、8、10水平变化。选择同期正常妊娠晚期孕妇30例作为健康组。结果观察组患者治疗前血清IL-6、8水平明显高于健康组,IL-10水平明显低于健康组(P<0.01)。治疗1周后,观察组患者血清IL-6、8水平较前明显下降,IL-10水平较前明显上升(P<0.05)。结论 HDCP患者存在炎症细胞因子水平紊乱,体内存在局部炎症反应。血清IL-6、8、10水平改变反映了HDCP病情程度,可作为治疗疗效评估的指标。 Objective To observe the changes of serum interleukin-6, 8, and 10 of hypertensive disorder complicating pregnancy (HDCP) patients before and after medical treatment. Methods Fifty cases of HDCP patients were selected as observed group, who were given regular medical treatment of relieving spasm, tranquilizing mind, controlling blood pressure and promoting diereses for 1 week. the changes of serum interleukin-6, 8, and 10 of patients in observed group before and after medical treatment and clinical effect were observed. 30 cases of normal women in late pregnancy were selected as health group. Results The serum interleukin-6, 8, and 10 levels of patients in observed group were obviously lower than that in health group (P 〈 0.01). After medical treatment, the serum interleukin-6, and 8 levels of patients in observed group had sharply declined, but serum interleukin-10 level had rose obviously than before (P 〈 0.05). Coulusion There is existence of inflammatory cytokines in disorder in HDCP patients. The changes of the serum interleukin-6, 8, and 10 levels show the severity and change of disease of HDCP, which can be the evaluation index of the HDCP curative effect.
出处 《中国现代医生》 2013年第28期40-41,共2页 China Modern Doctor
基金 浙江省医学会临床科研基金(2011ZYCB05)
关键词 妊娠高血压疾病 白介素-6 白介素-8 白介素-10 Hypertensive disorder complicating pregnancy (HDCP) Interleukin-6 Interleukin-8 Intcrleukin-10
  • 相关文献

参考文献14

  • 1Lain KY,Roberts M. Contemporary concepts of the pathogenesis and management of pre-eclampsia[J]. JAMA,2002,287 (24) : 3183-3186.
  • 2Mahaneem M ,Ernest TL,Harbindar JS,et al. Tissue Kallikrein and kininogen levels in fetoplacental tissues from normotensive pregnant women and women with pregnancyin-duced hypertension[J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2007,134( 1 ) : 15-19.
  • 3潘爱萍,林寒梅.血清瘦素及炎性细胞因子改变在妊娠高血压疾病中的诊断价值[J].陕西医学杂志,2008,37(3):341-343. 被引量:10
  • 4Shi YY. Reserch advancement of PIH[J]. Foreign Medicine, Geneaic Health, 2006,25 (4) : 200-202.
  • 5Redman CW,Sargent IL. Latest advances in under standing preeclamp- sia[J]. Science, 2005,308 (5728) : 1592-1594.
  • 6Dekker GA,Sibai BM. Etiology and pathogenesis of preeclampsia: Current concept[J]. Am J Obstet Gynecol, 1998,179(5) : 1359-1360.
  • 7Hawfield A, Freeedman BI. Pre-eclampsia: the pivotal role of the pla- centa in its pathophysiology and markers for early detection[J]. The Adv Cardiovasc Dis, 2009,3 ( 1 ) : 65-73.
  • 8Peng M,Yu L,Ding YL,et al. Trophoblast cells invaing the placenta bed and change of spiral arteries and microvessels in pre-eclampsia[J]. Zhong Nan Da Xue Xue Bao Yi Xue Ban,2008,33(2) : 121-129.
  • 9乔福元,吴媛媛.妊娠期高血压疾病病因的研究现状及进展[J].华中医学杂志,2005,29(6):399-400. 被引量:31
  • 10王亚萍,王玉凤,曹艳红,李振华,王金美.西宁地区妊娠高血压疾病患者ET-1、IL-6水平测定及临床意义[J].青海医药杂志,2012,42(4):8-10. 被引量:2

二级参考文献22

  • 1沙志一,金惠铭.肿瘤坏死因子对体外培养的血管内皮细胞的作用[J].中国病理生理杂志,1995,11(5):455-459. 被引量:23
  • 2乔福元,吴媛媛.妊娠期高血压疾病病因的研究现状及进展[J].华中医学杂志,2005,29(6):399-400. 被引量:31
  • 3张丹晖.妊高征患者相关血管活性物质测定的临床意义[J].放射免疫学杂志,2006,19(6):487-488. 被引量:21
  • 4Redman CW, Sargent IL. Latest advances in understanding preeclampsia [J ]. Science, 2005, 308 (5728) : 1592-1594.
  • 5Maynard SE, Min JY,Merchan J,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia [J]. J Clin Invest, 2003,111 (5) : 649-658.
  • 6Marzi M,Vigano A,Trabattoni D,et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy [J]. Clin Exp Immunol,1996,106:127-133.
  • 7Tedgui A, Mallat Z. Anti-inflammatory mechanisms in the vascular wall[J]. Circ Res, 2001,88: 877-887.
  • 8Nuamah MA, Yura S, Sagawa N, et al. Significant increase in maternal plasma leptin concentration in induced delivery, a possible contribution of proinflammatory cytokines to placental leptin secretion [J]. Endocr J,2004,51(2):177-187.
  • 9Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia : Current concept. Am J Obstet Gynecol. 1998,179(5) :1359.
  • 10Teran E, Escudero C, Moya W, et al. Eelevated c - reactive protein and pro - inflammatory cytokines in andean women with preeclampsia. Int J Gynecol Obstet. 2001,75(3) :243.

共引文献49

同被引文献27

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部